ZEVRA THERAPEUTICS INC
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
ZVRA$12.14+4.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
FORM 10-K
| Page | ||
|---|---|---|
| PART I | ||
| Item 1. | Business | 7 |
| Item 1A. | Risk Factors | 30 |
| Item 1B. | Unresolved Staff Comments | 81 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.